Pure erythroid leukemia is characterized by biallelic <i>TP53</i> inactivation and abnormal p53 expression patterns in <i>de novo</i> and secondary cases

Hong Fang, Sa A. Wang, Joseph D. Khoury, Siba El Hussein, Do H. Kim, Mehrnoosh Tashakori, Zhenya Tang, Shaoying Li, Zhìhóng Hú, Fatima Zahra Jelloul, Keyur P. Patel, Timothy J. McDonnell, Tapan M. Kadia, L. Jeffrey Medeiros, Wei Wang